• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液链球菌产生的抗化脓性链球菌细菌素样抑制物质(BLIS)预防链球菌性咽炎

Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

作者信息

Tagg J R

机构信息

Department of Microbiology, University of Otago, P.O. Box 56, Dunedin, New Zealand.

出版信息

Indian J Med Res. 2004 May;119 Suppl:13-6.

PMID:15232154
Abstract

BACKGROUND & OBJECTIVES: Streptococcus salivarius is a numerically prominent member of the human oral microbiota that produces a variety of bacteriocin-like inhibitory substances (BLIS) having in vitro inhibitory activity against S. pyogenes. Our previous studies of S. salivarius isolates from children using a deferred antagonism BLIS production (P)-typing scheme showed that the 9 per cent of children having large populations of P-type 677 S. salivarius experienced fewer S. pyogenes acquisitions than either the 11 per cent of children having predominant P-type 226 populations or the 60 per cent of children with largely non-inhibitory (P-type 000) S. salivarius. Amongst the other BLIS P-types detected were a number of strongly-inhibitory (P-type 777) S. salivarius. In the present study the inhibitory agents produced by prototype strains of P-types 226, 677 and 777 S. salivarius are compared.

METHODS

The prototype BLIS-producing S. salivarius strains SN, 20P3, and K12 were isolated from tongue swabbings. BLIS P-typing was done using standard procedures. The BLIS molecules were purified and characterized.

RESULTS

S. salivarius SN (P-type 226) produces a heat-labile muramidase. S. salivarius 20P3 (P-type 677) produces the 2315 Da lantibiotic salivaricin A and S. salivarius K12 (P-type 777) produces two lantibiotics; salivaricin A2 (2368 Da) and salivaricin B (2733 Da).

INTERPRETATION & CONCLUSION: The P-type 777 S. salivarius strain produced salivaricin A2 and salivaricin B. The combined production of two anti-S. pyogenes BLIS activities by this strain indicates that it could be adopted as a colonizing strain in bacterial interference trials.

摘要

背景与目的

唾液链球菌是人类口腔微生物群中数量上占突出地位的成员,可产生多种类细菌素抑制物质(BLIS),对化脓性链球菌具有体外抑制活性。我们之前采用延迟拮抗BLIS产生(P)分型方案对儿童分离出的唾液链球菌进行研究,结果显示,9%唾液链球菌P型677数量多的儿童,其化脓性链球菌感染发生率低于11%唾液链球菌P型226占主导的儿童,也低于60%唾液链球菌基本无抑制作用(P型000)的儿童。在检测到的其他BLIS P型中,有一些是强抑制性(P型777)唾液链球菌。在本研究中,对P型226、677和777唾液链球菌的原型菌株产生的抑制剂进行了比较。

方法

从舌拭子中分离出产生BLIS的唾液链球菌原型菌株SN、20P3和K12。采用标准程序进行BLIS P分型。对BLIS分子进行纯化和表征。

结果

唾液链球菌SN(P型226)产生一种热不稳定的胞壁质酶。唾液链球菌20P3(P型677)产生2315 Da的羊毛硫抗生素唾液乳链菌肽A,唾液链球菌K12(P型777)产生两种羊毛硫抗生素;唾液乳链菌肽A2(2368 Da)和唾液乳链菌肽B(2733 Da)。

解读与结论

P型777唾液链球菌菌株产生唾液乳链菌肽A2和唾液乳链菌肽B。该菌株联合产生两种抗化脓性链球菌的BLIS活性,表明它可作为细菌干扰试验中的定植菌株。

相似文献

1
Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.唾液链球菌产生的抗化脓性链球菌细菌素样抑制物质(BLIS)预防链球菌性咽炎
Indian J Med Res. 2004 May;119 Suppl:13-6.
2
The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.化脓性链球菌的补体抑制剂(SIC)可保护化脓性链球菌免受唾液链球菌产生的类细菌素抑制物质(BLIS)的影响。
FEMS Microbiol Lett. 2009 Sep;298(1):67-73. doi: 10.1111/j.1574-6968.2009.01696.x.
3
Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.B族链球菌类细菌素抑制物质:对链球菌产生的类细菌素活性的一些个人见解,有好有坏。
Probiotics Antimicrob Proteins. 2009 Jun;1(1):60-6. doi: 10.1007/s12602-008-9002-7. Epub 2009 Feb 21.
4
Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.口腔链球菌产生羊毛硫抗生素唾液乳杆菌素A及其变体,并使用特定诱导试验检测其在人类唾液中的存在。
Appl Environ Microbiol. 2006 Feb;72(2):1459-66. doi: 10.1128/AEM.72.2.1459-1466.2006.
5
Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.唾液乳杆菌素A2和新型羊毛硫抗生素唾液乳杆菌素B由口腔益生菌唾液链球菌K12中一个190千碱基的可转移大质粒上的相邻基因座编码。
Appl Environ Microbiol. 2007 Feb;73(4):1107-13. doi: 10.1128/AEM.02265-06. Epub 2006 Dec 28.
6
Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.唾液链球菌和化脓性链球菌之间由SalA和SalA1羊毛硫抗生素肽介导的种内和种间信号传导。
J Bacteriol. 2001 Jul;183(13):3931-8. doi: 10.1128/JB.183.13.3931-3938.2001.
7
The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue.摄入添加了产唾液乳杆菌素A的唾液链球菌的牛奶对舌头上链球菌群体的类细菌素抑制活性的影响。
FEMS Microbiol Ecol. 2007 Mar;59(3):584-91. doi: 10.1111/j.1574-6941.2006.00228.x. Epub 2006 Oct 27.
8
Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?鼻咽部正常菌群产生的类细菌素抑制物质(BLIS):预防中耳炎的潜力?
J Med Microbiol. 2003 Sep;52(Pt 9):829-833. doi: 10.1099/jmm.0.05259-0.
9
Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.唾液乳链菌肽G32,一种原型化脓性链球菌类乳链菌肽SA-FF22的同源物,由共生菌唾液链球菌产生。
Int J Microbiol. 2012;2012:738503. doi: 10.1155/2012/738503. Epub 2012 Apr 8.
10
Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.巨大质粒编码唾液链球菌中不同组合的羊毛硫抗生素。
Antonie Van Leeuwenhoek. 2006 Oct;90(3):269-80. doi: 10.1007/s10482-006-9081-y. Epub 2006 Jul 27.

引用本文的文献

1
Description of the draft genome sequence of eK12, a derivative of the probiotic strain K12 with a modified plasmid.益生菌菌株K12的衍生物eK12的基因组序列草图描述,该衍生物带有一个经过修饰的质粒。
Microbiol Resour Announc. 2025 Aug 14;14(8):e0035525. doi: 10.1128/mra.00355-25. Epub 2025 Jul 8.
2
Environmental pH controls antimicrobial production by human probiotic .环境pH值控制人类益生菌的抗菌物质产生。
J Bacteriol. 2025 Jun 24;207(6):e0005925. doi: 10.1128/jb.00059-25. Epub 2025 Jun 2.
3
The Relationship Between Bacterial Flora in Saliva and Esophageal Mucus and Endoscopic Severity in Patients with Eosinophilic Esophagitis.
嗜酸性食管炎患者唾液和食管黏液中的细菌菌群与内镜严重程度的关系
Int J Mol Sci. 2025 Mar 26;26(7):3026. doi: 10.3390/ijms26073026.
4
Inhibition of pneumococcal growth and biofilm formation by human isolates of and .人源[具体物质1]和[具体物质2]分离株对肺炎球菌生长及生物膜形成的抑制作用
Appl Environ Microbiol. 2025 Mar 19;91(3):e0133624. doi: 10.1128/aem.01336-24. Epub 2025 Feb 26.
5
Development of Synthetic Antimicrobial Peptides Based on Genomic Analysis of Streptococcus salivarius.基于唾液链球菌基因组分析的合成抗菌肽的开发
J Clin Lab Anal. 2025 Feb;39(4):e25156. doi: 10.1002/jcla.25156. Epub 2025 Jan 24.
6
Role as a Probiotic in Children's Health and Disease Prophylaxis-A Systematic Review.益生菌在儿童健康与疾病预防中的作用——一项系统综述
Life (Basel). 2024 Dec 5;14(12):1613. doi: 10.3390/life14121613.
7
Probiotics in the management of radiation-induced oral mucositis.益生菌在放射性口腔黏膜炎管理中的应用。
Front Cell Infect Microbiol. 2024 Sep 18;14:1477143. doi: 10.3389/fcimb.2024.1477143. eCollection 2024.
8
Evaluation of the effects of probiotic pills on the oral plaque indices: A randomized clinical trial.益生菌丸对口腔菌斑指数影响的评估:一项随机临床试验。
Dent Res J (Isfahan). 2024 Jul 12;21:38. eCollection 2024.
9
Evaluation of the effects of M18 and K12 probiotic bacteria on the in saliva: A randomized clinical trial.评估M18和K12益生菌对唾液中[具体物质未提及]的影响:一项随机临床试验。
Dent Res J (Isfahan). 2024 Jul 12;21:39. eCollection 2024.
10
Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics.利用产生类细菌素抑制物质的链球菌益生菌对口腔及其他部位的人类健康进行有益调节。
Front Microbiol. 2023 Mar 28;14:1161155. doi: 10.3389/fmicb.2023.1161155. eCollection 2023.